The Africa Clinical Research Network (ACRN) has started its first clinical trial using Oracle's cloud-based safety and analytics solutions to study pre-eclampsia in African women. The PROTECT-Africa trial, running in Zimbabwe, Rwanda, and Tanzania, aims to validate biomarkers that predict severe pregnancy complications, recruiting over 1,100 participants. This initiative addresses the low representation of Africa in global clinical trials and seeks to build a sustainable research ecosystem across 14 African countries. By leveraging Oracle's technology, ACRN aims to enhance trial efficiency, patient safety, and accelerate access to relevant medical innovations for African populations.
Oracle is reaffirmed as a buy due to its strong AI-driven growth and accelerating cloud infrastructure revenue, which rose 93% year-over-year. The company expects $90 billion in revenue and $8.05 non-GAAP EPS for fiscal 2027, despite temporary margin...
Global equities rebounded in the second quarter driven by optimism around AI investments, with major tech companies planning to spend $1 trillion on AI by 2027. However, the market now expects near-perfect AI execution, leaving little room for error....
Several major companies including Boeing, Lockheed Martin, and Oracle are sponsoring Freedom 250, a Trump-aligned celebration of America's 250th birthday. The event offers high-dollar donors VIP access to President Trump, sparking concerns from watch...
Oracle has revealed a massive $638 billion backlog in AI infrastructure contracts, representing nearly a decade of revenue and signaling strong future growth. This backlog surged 363% last quarter with $67 billion in new AI deals, prompting managemen...
Meta Platforms is developing a cloud business to monetize its excess AI computing capacity, potentially boosting near-term revenue by offering AI model access or raw compute power. Nike reported strong Q4 profits and sales but faces ongoing challenge...
